Svea B.

Svea B. currently serves as a Scientist in Biology at Tubulis GmbH since May 2024. Prior experience includes roles as a Junior Research Scientist and PhD Student at Uniklinik RWTH Aachen from January 2019 to December 2023, where research focused on the impact of fasting regimens on tumor-directed drug delivery. Svea has also interned at Merck KGaA, contributing to the development of antibody-drug conjugates and other relevant projects. Educational background includes a PhD in Biochemistry and Molecular Biology from RWTH Aachen University, a Master of Science in Technical Biology, and a Bachelor of Science in Biology, both from Technische Universität Darmstadt.